{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:52:11Z","timestamp":1777560731388,"version":"3.51.4"},"reference-count":58,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJGM"],"DOI":"10.2147\/ijgm.s294896","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T09:20:10Z","timestamp":1636363210000},"page":"7797-7805","source":"Crossref","is-referenced-by-count":5,"title":["Long-Term Pharmacological Management of Reduced Ejection Fraction Following Acute Myocardial Infarction: Current Status and Future Prospects"],"prefix":"10.2147","volume":"Volume 14","author":[{"given":"Alexandra AI","family":"Abel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1093\/eurheartj\/ehn096","volume":"29","author":"Torabi","year":"2008","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0002-9149(96)00576-0","volume":"78","author":"Kober","year":"1996","journal-title":"Am J Cardiol"},{"key":"ref3","unstructured":"National Institute for Health and Clinical Excellence NG185 \u2013 acute Coronary Syndromes. London: NICE; 2020. Available from: nice.org.uk\/guidance\/ng185. Accessed July 1, 2021."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S1388-9842(00)00100-8","volume":"2","author":"Houghton","year":"2000","journal-title":"Eur J Heart Fail"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction inpatients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385\u20131390. doi:10.1016\/S0140-6736(00)04560-8","DOI":"10.1016\/S0140-6736(00)04560-8"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"McDonagh","year":"2016","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ahj.2018.10.005","volume":"208","author":"Munkhaugen","year":"2019","journal-title":"Am Heart J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s13063-020-4214-6","volume":"21","author":"Kristensen","year":"2020","journal-title":"Trials"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","volume":"333","author":"K\u00f8ber","year":"1995","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Study TA. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet. 1993;342:821\u2013828.","DOI":"10.1016\/0140-6736(93)92693-N"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJM199209033271001","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/heartjnl-2020-316823","volume":"107","author":"Wu","year":"2021","journal-title":"Heart"},{"key":"ref15","first-page":"1115","volume":"343","author":"Vecchio","year":"1994","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(95)90865-X","volume":"345","author":"Collins","year":"1995","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1056\/NEJMoa032292","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12872-015-0033-1","volume":"15","author":"Miller","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.21037\/apm-21-563","volume":"10","author":"Wang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1056\/NEJMoa042934","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijcard.2015.05.160","volume":"196","author":"Farag","year":"2015","journal-title":"Int J Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ahj.2020.09.020","volume":"231","author":"Wiggers","year":"2021","journal-title":"Am Heart J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12968-018-0494-3","volume":"20","author":"Bulluck","year":"2018","journal-title":"J Cardiovasc Magn Reson"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Sixty Plus Reinfarction Study Research Group. A double-blind trial to assess long-term oral anticoagulant therapy in elderly patients after myocardial infarction. Report of the Sixty Plus Reinfarction Study Research Group. Lancet. 1980;2:989\u2013994.","DOI":"10.1016\/S0140-6736(80)92154-6"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1056\/NEJM199007193230302","volume":"323","author":"Smith","year":"1990","journal-title":"N Engl J Med"},{"key":"ref30","first-page":"499","volume":"343","author":"Jonker","year":"1994","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.carrev.2017.05.002","volume":"18","author":"Moulson","year":"2017","journal-title":"Cardiovasc Revasc Med"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa1112277","volume":"366","author":"Mega","year":"2012","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","volume":"377","author":"Eikelboom","year":"2017","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0140-6736(17)32458-3","volume":"391","author":"Connolly","year":"2018","journal-title":"Lancet"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1056\/NEJMoa1808848","volume":"379","author":"Zannad","year":"2018","journal-title":"N Engl J Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e383","DOI":"10.1055\/s-0040-1720961","volume":"4","author":"Nygaard","year":"2020","journal-title":"TH Open"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1161\/CIRCULATIONAHA.108.832139","volume":"119","author":"Alexander","year":"2009","journal-title":"Circulation"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1105819","volume":"365","author":"Alexander","year":"2011","journal-title":"N Engl J Med"},{"key":"ref39","unstructured":"National Institute for Health and Care Excellence. Rivaroxaban for Preventing Adverse Outcomes After Acute Management of Acute Coronary Syndrome. Technology appraisal guidance [TA335]; 2015."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.hlc.2017.10.023","volume":"28","author":"Hay\u0131ro\u011flu","year":"2019","journal-title":"Heart Lung Circ"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1093\/eurheartj\/ehi696","volume":"27","author":"de Silva","year":"2006","journal-title":"Eur Heart J"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/qjmed\/hct222","volume":"107","author":"Zachariah","year":"2014","journal-title":"QJM"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/heartjnl-2018-314158","volume":"105","author":"Clark","year":"2019","journal-title":"Heart"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/ejhf.788","volume":"19","author":"Pellicori","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1056\/NEJMoa2025797","volume":"384","author":"Teerlink","year":"2021","journal-title":"N Engl J Med"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ejhf.2191","volume":"23","author":"Jering","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"ref53","unstructured":"Presented by Dr. Marc Pfeffer at the American College of Cardiology Virtual Annual Scientific Session (ACC 2021), May 15, 2021."},{"key":"ref54","unstructured":"National Institute for Health and Clinical Excellence QS103. Chronic heart failure in adults. London: NICE; 2018. Available from: nice.org.uk\/guidance\/qs9\/chapter\/List-of-quality-statements. Accessed October 26, 2021."},{"key":"ref55","unstructured":"Clinicaltrials.gov. EMPACT-MI: a Streamlined, Multicentre, Randomised, Parallel Group, Double-blind Placebo-controlled Superiority Trial to Evaluate the Effect of EMPAgliflozin on Hospitalisation for Heart Failure and Mortality in Patients With aCuTe Myocardial Infarction. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04509674. Accessed July 1, 2021."},{"key":"ref56","unstructured":"Clinicaltrials.gov. Dapagliflozin Effects on Cardiovascular Events in Patients With an Acute Heart Attack (DAPA-MI). Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04564742. Accessed July 1, 2021."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"}],"container-title":["International Journal of General Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=75609","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=75609","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T10:34:38Z","timestamp":1699785278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/long-term-pharmacological-management-of-reduced-ejection-fraction-foll-peer-reviewed-fulltext-article-IJGM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":58,"URL":"https:\/\/doi.org\/10.2147\/ijgm.s294896","relation":{},"ISSN":["1178-7074"],"issn-type":[{"value":"1178-7074","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11]]}}}